Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence

Drug and Alcohol Dependence

Volumn 117, Issue 2-3, 2011, Pages 102-110

  Erdozain, Amaia M ^a,b   Callado, Luis F ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Alcohol dependence; Cannabinoids; Endocannabinoid system; Receptors; Rimonabant

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; PLACEBO; RIMONABANT;

ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIOCHEMISTRY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; DRINKING BEHAVIOR; DRUG SEEKING BEHAVIOR; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; NEUROBIOLOGY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RELAPSE; REVIEW; SOCIAL BEHAVIOR;

ALCOHOLISM; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ENDOCANNABINOIDS; ETHANOL; FEMALE; HUMANS; MALE; PHENOTYPE; RECEPTORS, CANNABINOID;

RODENTIA;

EID: 79960844667     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.02.003     Document Type: Review

References (90)

1. Alen F., Moreno-Sanz G., Isabel de Tena A., Brooks R.D., Lopez-Jimenez A., Navarro M., Lopez-Moreno J.A. Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse. Eur. J. Neurosci. 2008, 27:3292-3298.
2. Alexander S.P.H., Kendall D.A. The life cycle of the endocannabinoids: formation and inactivation. Behavioral Neurobiology of the Endocannabinoid System 2009, Springer, New York. S.P.H. Alexander, D.A. Kendall (Eds.).
3. Alvarez-Jaimes L., Stouffer D.G., Parsons L.H. Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. J. Neurochem. 2009, 111:37-48.
4. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 1997, 132:104-106.
5. Basavarajappa B.S., Cooper T.B., Hungund B.L. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res. 1998, 793:212-218.
6. Basavarajappa B.S., Hungund B.L. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J. Neurochem. 1999, 72:522-528.
7. Basavarajappa B.S., Hungund B.L. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice. J. Neurosci. Res. 2001, 64:429-436.
8. Basavarajappa B.S., Saito M., Cooper T.B., Hungund B.L. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim. Biophys. Acta 2000, 1535:78-86.
9. Basavarajappa B.S., Yalamanchili R., Cravatt B.F., Cooper T.B., Hungund B.L. Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 2006, 50:834-844.
10. Benyamina A., Kebir O., Blecha L., Reynaud M., Krebs M.O. CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict. Biol. 2011, 16:1-6.
11. Blednov Y.A., Cravatt B.F., Boehm S.L., Walker D., Harris R.A. Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology 2007, 32:1570-1582.
12. Caille S., Alvarez-Jaimes L., Polis I., Stouffer D.G., Parsons L.H. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J. Neurosci. 2007, 27:3695-3702.
13. Chiang K.P., Gerber A.L., Sipe J.C., Cravatt B.F. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 2004, 13:2113-2119.
14. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007, 370:1706-1713.
15. Cippitelli A., Bilbao A., Gorriti M.A., Navarro M., Massi M., Piomelli D., Ciccocioppo R., Rodriguez de Fonseca F. The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur. J. Neurosci. 2007, 26:476-486.
16. Cippitelli A., Bilbao A., Hansson A.C., del Arco I., Sommer W., Heilig M., Massi M., Bermudez-Silva F.J., Navarro M., Ciccocioppo R., Rodriguez de Fonseca F. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur. J. Neurosci. 2005, 21:2243-2251.
17. Cohen C., Perrault G., Voltz C., Steinberg R., Soubrie P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol. 2002, 13:451-463.
18. Colombo G., Agabio R., Fa M., Guano L., Lobina C., Loche A., Reali R., Gessa G.L. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol. 1998, 33:126-130.
19. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., Carai M.M., Gessa L. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl.) 2002, 159:181-187.
20. Colombo G., Vacca G., Serra S., Carai M.A., Gessa G.L. Suppressing effect of the cannabinoid CB1 receptor antagonist SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur. J. Pharmacol. 2004, 498:119-123.
21. Comings D.E., Muhleman D., Gade R., Johnson P., Verde R., Saucier G., MacMurray J. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol. Psychiatry 1997, 2:161-168.
22. De Bruin N.M.W.J., Lange J.H.M., Kruse C.G., Herremans A.H., Schoffelmeer A.N.M., van Drimmelen M., De Vries T.J. SLV330 a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behav. Brain Res. 2011, 217:408-415.
23. Diamond I., Gordon A.S. Cellular and molecular neuroscience of alcoholism. Physiol. Rev. 1997, 77:1-20.
24. Dyr W., Ligieza J., Kostowski W. The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol 2008, 42:509-512.
25. European Medicines Agency Public Statement on Zimulti (Rimonabant) Withdrawal of the Marketing Authorisation in the European Union 2009, (accessed on 2010/10/18). European Medicines Agency EMEA/39560/2009. http://www.ema.europa.eu/humandocs/PDFs/EPAR/zimulti/3956009en.pdf.
26. Ferrer B., Bermudez-Silva F.J., Bilbao A., Alvarez-Jaimes L., Sanchez-Vera I., Giuffrida A., Serrano A., Baixeras E., Khaturia S., Navarro M., Parsons L.H., Piomelli D., Rodriguez de Fonseca F. Regulation of brain anandamide by acute administration of ethanol. Biochem. J. 2007, 404:97-104.
27. Flanagan J.M., Gerber A.L., Cadet J.L., Beutler E., Sipe J.C. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum. Genet. 2006, 120:581-588.
28. Freedland C.S., Sharpe A.L., Samson H.H., Porrino L.J. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol. Clin. Exp. Res. 2001, 25:277-282.
29. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 1995, 232:54-61.
30. Gallate J.E., McGregor I.S. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berl.) 1999, 142:302-308.
31. Gallate J.E., Saharov T., Mallet P.E., McGregor I.S. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur. J. Pharmacol. 1999, 370:233-240.
32. George D.T., Herion D.W., Jones C.L., Phillips M.J., Hersh J., Hill D., Heilig M., Ramchandani V.A., Geyer C., Spero D.E., Singley D.E., O'Malley S.S., Bishai R., Rawlings R.R., Kunos G. Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology (Berl.) 2010, 208:37-44.
33. Gessa G.L., Serra S., Vacca G., Carai M.A., Colombo G. Suppressing effect of the cannabinoid CB1 receptor antagonist SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol. 2005, 40:46-53.
34. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
35. Gonzalez S., Cascio M.G., Fernandez-Ruiz J., Fezza F., Di Marzo V., Ramos J.A. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 2002, 954:73-81.
36. Gonzalez S., Fernandez-Ruiz J., Sparpaglione V., Parolaro D., Ramos J.A. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend. 2002, 66:77-84.
37. Gonzalez S., Valenti M., de Miguel R., Fezza F., Fernandez-Ruiz J., Di Marzo V., Ramos J.A. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Br. J. Pharmacol. 2004, 143:455-464.
38. Hansson A.C., Bermudez-Silva F.J., Malinen H., Hyytia P., Sanchez-Vera I., Rimondini R., Rodriguez de Fonseca F., Kunos G., Sommer W.H., Heilig M. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 2007, 32:117-126.
39. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., Ferrell R.E., Goldman D., Manuck S.B. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2009, 66:9-16.
40. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
41. Herman A.I., Kranzler H.R., Cubells J.F., Gelernter J., Covault J. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141B:499-503.
42. Houchi H., Babovic D., Pierrefiche O., Ledent C., Daoust M., Naassila M. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 2005, 30:339-349.
43. Hungund B.L., Basavarajappa B.S. Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. J. Neurosci. Res. 2000, 60:122-128.
44. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem. 2003, 84:698-704.
45. Hutchison K.E., Haughey H., Niculescu M., Schacht J., Kaiser A., Stitzel J., Horton W.J., Filbey F. The incentive salience of alcohol: translating the effects of genetic variant in CNR1. Arch. Gen. Psychiatry 2008, 65:841-850.
46. Ishiguro H., Iwasaki S., Teasenfitz L., Higuchi S., Horiuchi Y., Saito T., Arinami T., Onaivi E.S. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J. 2007, 7:380-385.
47. Iwasaki S., Ishiguro H., Higuchi S., Onaivi E.S., Arinami T. Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population. Psychiatr. Genet. 2007, 17:215-220.
48. Kelai S., Hanoun N., Aufrere G., Beauge F., Hamon M., Lanfumey L. Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice. J. Neurochem. 2006, 99:308-320.
49. Köhnke M.D. Approach to the genetics of alcoholism: a review based on pathophysiology. Biochem. Pharmacol. 2008, 75:160-177.
50. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
51. Lallemand F., De Witte P. Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference. Alcohol Alcohol. 2005, 40:54-62.
52. Lallemand F., De Witte P. SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats. Alcohol 2006, 39:125-134.
53. Lallemand F., Soubrie P.H., De Witte P.H. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin. Exp. Res. 2001, 25:1317-1323.
54. Lehtonen M., Storvik M., Tupala E., Hyytia P., Tiihonen J., Callaway J.C. Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics. Eur. Neuropsychopharmacol. 2010, 20:245-252.
55. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
56. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006, 29:225-232.
57. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 1993, 327:535-550.
58. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
59. Mitrirattanakul S., Lopez-Valdes H.E., Liang J., Matsuka Y., Mackie K., Faull K.F., Spigelman I. Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence. Alcohol. Clin. Exp. Res. 2007, 31:855-867.
60. Moranta D., Esteban S., Garcia-Sevilla J.A. Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivo. Neurosci. Lett. 2006, 392:58-61.
61. Munro S., Thomas K.L., bu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
62. Naassila M., Pierrefiche O., Ledent C., Daoust M. Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 2004, 46:243-253.
63. Oliva J.M., Ortiz S., Perez-Rial S., Manzanares J. Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain. Eur. Neuropsychopharmacol. 2008, 18:373-382.
64. Ortiz S., Oliva J.M., Perez-Rial S., Palomo T., Manzanares J. Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol. 2004, 39:88-92.
65. Ortiz S., Oliva J.M., Perez-Rial S., Palomo T., Manzanares J. Differences in basal cannabinoid CB1 receptor function in selective brain areas and vulnerability to voluntary alcohol consumption in Fawn Hooded and Wistar rats. Alcohol Alcohol. 2004, 39:297-302.
66. Ponce G., Hoenicka J., Rubio G., Ampuero I., Jimenez-Arriero M.A., Rodriguez-Jimenez R., Palomo T., ramos J.A. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol. Psychiatry 2003, 8:466-467.
67. Poncelet M., Maruani J., Calassi R., Soubrie P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci. Lett. 2003, 343:216-218.
68. Preuss U.W., Koller G., Zill P., Bondy B., Soyka M. Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur. Arch. Psychiatry Clin. Neurosci. 2003, 253:275-280.
69. Racz I., Bilkei-Gorzo A., Toth Z.E., Michel K., Palkovits M., Zimmer A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J. Neurosci. 2003, 23:2453-2458.
70. Rinaldi-Carmona M., Barth F., Congy C., Martinez S., Oustric D., Perio A., Poncelet M., Maruani J., Arnone M., Finance O., Soubrie P., Le Fur G. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyr azole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 2004, 310:905-914.
71. Rodriguez de Fonseca F., Roberts A.J., Bilbao A., Koob G.F., Navarro M. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Zhongguo Yao Li Xue Bao 1999, 20:1109-1114.
72. Rubio M., de Miguel R., Fernandez-Ruiz J., Gutierrez-Lopez D., Carai M.A., Ramos J.A. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug Alcohol Depend. 2009, 99:354-358.
73. Rubio M., McHugh D., Fernandez-Ruiz J., Bradshaw H., Walker J.M. Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci. Lett. 2007, 421:270-274.
74. Schmidt L.G., Samochowiec J., Finckh U., Fiszer-Piosik E., Horodnicki J., Wendel B., Rommelspacher H., Hoehe M.R. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend. 2002, 65:221-224.
75. Serra S., Brunetti G., Pani M., Vacca G., Carai M.A., Gessa G.L., Colombo G. Blockade by the cannabinoid CB(1) receptor antagonist SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur. J. Pharmacol. 2002, 443:95-97.
76. Serra S., Carai M.A., Brunetti G., Gomez R., Melis S., Vacca G., Colombo G., Gessa G.L. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats. Eur. J. Pharmacol. 2001, 430:369-371.
77. Sipe J.C., Chiang K., Gerber A.L., Beutler E., Cravatt B.F. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8394-8399.
78. Soyka M., Koller G., Schmidt P., Lesch O.M., Leweke M., Fehr C., Gann H., Mann K.F. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J. Clin. Psychopharmacol. 2008, 28:317-324.
79. Thanos P.K., Dimitrakakis E.S., Rice O., Gifford A., Volkow N.D. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav. Brain Res. 2005, 164:206-213.
80. Tsou K., Nogueron M.I., Muthian S., Sanudo-Pena M.C., Hillard C.J., Deutsch D.G., Walker J.J. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci. Lett. 1998, 254:137-140.
81. Vinod K.Y., Arango V., Xie S., Kassir S.A., Mann J.J., Cooper T.B., Hungund B.L. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol. Psychiatry 2005, 57:480-486.
82. Vinod K.Y., Kassir S.A., Hungund B.L., Cooper T.B., Mann J.J., Arango V. Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J. Psychiatr. Res. 2010, 44:591-597.
83. Vinod K.Y., Sanguino E., Yalamanchili R., Manzanares J., Hungund B.L. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol. J. Neurochem. 2008, 104:233-243.
84. Vinod K.Y., Yalamanchili R., Xie S., Cooper T.B., Hungund B.L. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem. Int. 2006, 49:619-625.
85. Wang G.J., Volkow N.D., Franceschi D., Fowler J.S., Thanos P.K., Scherbaum N., Pappas N., Wong C.T., Hitzemann R.J., Felder C.A. Regional brain metabolism during alcohol intoxication. Alcohol. Clin. Exp. Res. 2000, 24:822-829.
86. Wang L., Liu J., Harvey-White J., Zimmer A., Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1393-1398.
87. World Health Organization Global Status Report on Alcohol 2004 2004, World Health Organization, Geneva.
88. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
89. Zhang P.W., Ishiguro H., Ohtsuki T., Hess J., Carillo F., Walther D., Onaivi E.S., Arinami T., Uhl G.R. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry 2004, 9:916-931.
90. Zuo L., Kranzler H.R., Luo X., Covault J., Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol. Psychiatry 2007, 62:616-626.